Back to Search
Start Over
Patient selection criteria and the FLEX Study.
- Source :
-
Lancet (London, England) [Lancet] 2009 May 02; Vol. 373 (9674), pp. 1497-8. - Publication Year :
- 2009
- Subjects :
- Antibodies, Monoclonal, Humanized
Biomarkers, Tumor analysis
Carcinoma, Non-Small-Cell Lung mortality
Carcinoma, Non-Small-Cell Lung pathology
Cetuximab
Clinical Trials, Phase III as Topic
Disease-Free Survival
ErbB Receptors analysis
Humans
Lung Neoplasms mortality
Lung Neoplasms pathology
Randomized Controlled Trials as Topic
Survival Rate
Antibodies, Monoclonal therapeutic use
Antineoplastic Combined Chemotherapy Protocols therapeutic use
Carcinoma, Non-Small-Cell Lung drug therapy
Lung Neoplasms drug therapy
Patient Selection
Subjects
Details
- Language :
- English
- ISSN :
- 1474-547X
- Volume :
- 373
- Issue :
- 9674
- Database :
- MEDLINE
- Journal :
- Lancet (London, England)
- Publication Type :
- Academic Journal
- Accession number :
- 19410696
- Full Text :
- https://doi.org/10.1016/S0140-6736(09)60834-5